Effects of octreotide pretreatment in experimental acute pancreatitis

Pancreatology

Volumn 3, Issue 2, 2003, Pages 164-168

  Salem, Marcelo Z ^a   Cunha, J Eduardo M ^a,b   Coelho, Ana M ^a   Sampietri, Sandra N ^a   Machado, Marcel C C ^a   Penteado, Sonia ^a   Abdo, Emílio E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Acute pancreatitis; Octreotide; Pancreatic enzymes; Pulmonary lesions

Indexed keywords

AMYLASE; CERULETIDE; ELASTASE; OCTREOTIDE; PANCREAS ENZYME; SODIUM CHLORIDE; TAUROCHOLIC ACID; TRYPSIN;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES FLUID ANALYSIS; BLOOD ANALYSIS; CONTROLLED STUDY; HISTOPATHOLOGY; LUNG EDEMA; LUNG INTERSTITIUM; MALE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RAT; RAT STRAIN;

EID: 0038057352     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000070086     Document Type: Article

References (27)

1. Fernández-Cruz L, Navarro S, Valderrama R, et al: Acute necrotizing pancreatitis: A multicenter study. Hepatogastroenterology 1994;41:185-189.
2. Adler G, Kern HF, Scheele GA: Experimental models and concepts of AP; in Go VLW, et al. (eds): The Exocrine Pancreas. New York, Raven Press, 1986, pp 407-421.
3. Machado MCC, Coelho AM, Kubrusly MS Bonizzia A, Pinotti HW: Reduction of pancreatic enzyme content and mortality in experimental AP in rats. Bras J Exp Med Biol Res 1995;28:471-475.
4. Cunha JEM, Salem MZ, Coelho AM, Kubrusly MS, Sampietri SN, Machado MCC: Influence of pancreatic enzyme reduction on pulmonary lesions of AP. HPB 2000;2:389-393.
5. Coelho AMM, Sampietri SM, Abdo EE, Cunha JEM, Machado MCC: Influence of pancreatic enzyme content on the pathogenesis of AP. 42th Ann Meet Soc for Surgery of the Alimentary Tract, 2001, vol 42, p 127.
6. Falconi M, Caldiron E, Zancanaro C, Benati D, Talamini G, Bassi C, Pederzoli P: In vivo octreotide administration acutely reduces exocrine granule size in human pancreas. Pancreatology 2001;1:30-35.
7. Cavallini G, Frulloni L: Somatostatin and octreotide in AP: The never-ending story. Dig Liver Dis 2001;33:192-201.
8. Greenberg R, Haddad R, Kashtan H, Kaplan O: The effects of somatostatin and octreotide on experimental and human AP. J Lab Clin Med 2000;135:112-121.
9. Kaplan O, Kaplan D, Cassif E, et al: Effect of delayed administration of octreotide in acute experimental pancreatitis. J Surg Res 1996;62:109-117.
10. Paran H, Mayo A, Paran D, Neufeld D, Shwartz I, Zissin R, Singer P, Kaplan O, Skornik Y, Freund U: Octreotide treatment in patients with severe AP. Dig Dis Sci 2000 Nov;45:2247-2251.
11. McKay C, Baxter J, Imrie C: A randomized controlled trial of octreotide in the management of patients with AP. Int J Pancreatol 1997;21:13-19.
12. Uhl W, Büchler MW, Malfertheiner P, Beger HG, Adler GA: A randomized, double-blind, multicenter trial of octreotide to severe AP. Gut 1999;45:97-104.
13. Schoenfeld J, Meisse F, Muller MK: Rat pancreas after long-term treatment with somatostatin analogue octreotide. Exp Physiol 1995;80:1031-1038.
14. Hardt PD, Doppl WE, Marzeion A, Franke V, et al: Effects of long-acting somatostatin analogue octreotide on the morphology of human pancreatic acini in vitro. Pancreas 1995;11:431.
15. Lankisch PG, Ihse I: Bile-induced acute experimental pancreatitis. Scand J Gastroenterol 1987;22:257-260.
16. Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Mandavilli U, Knoefel WT, Warshaw AL: A better model of acute pancreatitis for evaluating therapy. Ann Surg 1992;215:44-56.
17. Milani Junior RJ, Pereira PM, Dolhnikoff M, Saldiva PH, Martins MA: Respiratory mechanics and lung morphometry in severe pancreatitis-associated acute lung injury in rats. Crit Care Med 1995;23:1882-1889.
18. Aherne WA: Quantitative methods in histology. J Med Lab Technol 1970;27:160-170.
19. Weibel ER: Morphometry: Stereological theory and practical methods; in Gil J (ed): Models of Lung Disease. Microscopy and Structural Methods. New York, Marcel Decker 1990, pp 199-247.
20. Adler G, Koch A, Kern HF: Effect of somatostatin on rat exocrine pancreatic secretory process in normal and diseased state. Z Gastroenterol Verh 1980;18:418-426.
21. Rhie DJ, Kim MJ, Choi WS, Lee KH, Sung JH, Min DS, Yoon SH, Hahn SJ, Kim MS, Jo YH: Effect of somatostatin on cholecystokinin-induced amylase release in rat pancreatic acini. Pancreas 2001;23:102-108.
22. Testoni PA, Bagnolo F, Andriulli A, Bernasconi G, Crotta S, Lella F, Lomazzi A, Minoli G, Natale C, Prada A, Toti GL, Zambelli A: Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: Results of a multicenter, randomized, controlled trial. Aliment Pharmacol Ther 2001;15:965-972.
23. Manolakopoulos S, Avgerinos A, Vlachogiannakos J, Armonis A, Viazis N, Papadimitriou N, Mathou N, Stefanidis G, Rekoumis G, Vienna E, Tzourmakliotis D, Raptis SA: Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: A multicenter randomized controlled trial. Gastrointest Endosc 2002;55:470-475.
24. Leonhardt U, Seidensticker F, Stockmann F, Creutzfeldt W: Effect of camostate administration for two weeks on experimental pancreatitis in mice and rats. Pancreas 1993;8:98-102.
25. Yoshinaga K, Washizuka M, Segawa Y: Fasting exacerbates AP by occlusion of the common bile duct in rats. Jpn J Pharmacol 2000;84:455-461.
26. Montravers P, Chollet MS, Marmuse JP, Gougerot PMA, Desmonts JM: Lymphatic release of cytokines during acute lung injury complicating severe pancreatitis. Am J Respir Crit Care Med 1995;152:1527-1533.
27. Chen HM, Shyr MH, Chen MF: Gabexate mesilate improves pancreatic microcirculation and reduces lung edema in a rat model of AP. J Formosa Med Assoc 1997;96:704-709.